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caveat phrases in the original radiology 
interpretation. The studies were categorized 
into diagnostic, technically limited, or non-
diagnostic studies.






The diagnostic quality was superior when 
performed using ASIR-V, with 90% (481/533) 
of studies being diagnostic, compared to 80% 
(452/562; P<.0001) in the FBP group.
Conclusions: CTPA performed using ASIR-V 
both reduced radiation dose as well as 
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CTPA performed using FBP. 
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biological pathways and mutations is 
integral to improving outcomes in appendix 
peritoneal metastases (APM). Interrogation 
of cancers with Next Generation Sequencing 
(NGS) 50-gene mutation panels has become 
more widely utilized identifying prognostic 
and actionable mutations. This study is a 
dedicated analysis of the value of expanded 
mutation analysis in APM. 
Methods: The IRB approved study 
included 51 APM patients where data was 
retrospectively collected from a CRS/HIPEC 
registry treated 2012-2018. Standard clinical 
50-gene NGS analysis was performed in CLIA 
approved lab. All patients underwent CRS/
HIPEC with mitomycin C delivered for 90 
minutes at 41-42 C. Peritoneal Cancer Index 
(PCI), Completeness of Cytoreduction (CC) 
score, length of stay, progression free survival 
(PFS), overall survival (OS) were collected 
along with the rates and types of mutation in 
APM. OS and PFS analyses were performed 
on all, high grade (HG), and low grade (LG) 
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smad4 and p53 mutations on survival.
Results: Eighty-four percent of APM had 
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Smad4 or p53 mutation occurred in 25% 
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in all APM (22 vs 88 months p=0.0026) 
and HG APM (20 vs 47 months p=0.0502) 
was observed. Smad4 mutation was also 
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APM (p=0.0192). Actionable mutations were 
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Conclusion: Smad4 and p53 mutations were 
associated with more aggressive APM and 
maybe a useful tool in patient selection and 
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valuable in APM and further application is 






















OSALL 88 22 <0.01






PFSALL 10 3.5 0.02
PFSHG 6.5 1.5 0.01
PFSLG 20 7.5 0.09
